United States· US:80425-0207_2a99e9e8-3d1b-ee0b-e063-6294a90ae4ef
Lisinopril and Hydrochlorothiazide
A medicinal product containing hydrochlorothiazide; lisinopril, registered in United States by Advanced Rx Pharmacy of Tennessee, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1180425-0207-3
- ndc11804250207390 TABLET in 1 BOTTLE (80425-0207-3)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hydrochlorothiazide; lisinopril in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaLISINOPRIL/HCTZ (TYPE Z)SANIS HEALTH INC
- PolandLisiprol HCTGedeon Richter Polska Sp. z o.o.
- United KingdomCarace 10 Plus tabletsOrganon Pharma (UK) Ltd
- FinlandAcercompAstraZeneca Oy
- SwitzerlandCo-Lisinopril Spirig HC
- ItalyLISINOPRIL E IDROCLOROTIAZIDE DOC GENERICIDOC GENERICI S.R.L.
- GermanyAcercompAtnahs Pharma Netherlands B.V.
- SpainDONEKA PLUS 20/12.5 MG COMPRIMIDOSNeuraxpharm Spain S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Acecomb, Acecomb Mite
- Belgium · Co-Lisinopril, Co-Lisinopril Teva
- Bulgaria · Витоприл Плюс, Ко-Диротон
- Cyprus · Zestoretic
- Czechia · Skopryl Plus H
- Germany · Acercomp, Lisihexal Comp
- Denmark · Lisinoplus, Lisinopril-Hydrochlorthiazid Actavis
- Spain · Doneka Plus, Lisinopril/ Hidroclorotiazida Cinfa
- Finland · Lisinopril/Hydrochlorothiazide Orion
- France · Lisinopril/Hydrochlorothiazide Arrow Lab, Lisinopril/Hydrochlorothiazide Biogaran
- United Kingdom (Northern Ireland) · Lisinopril & Hydrochlorothiazide Bristol Laboratories, Lisinopril + Hct
- Greece · Zestoretic
- Croatia · Amicor H, Iruzid
- Hungary · Lisopress Hct, Skopryl Plus
- Ireland · Lispril-Hydrochlorothiazide, Zestoretic
- Italy · Lisinopril E Idroclorotiazide Doc Generici, Lisinopril E Idroclorotiazide Pensa
- Luxembourg · Co-Lisinopril Eg, Lisinopril Comp. Ratiopharm
- Malta · Zestoretic
- Netherlands · Lisinopril/Hydrochloorthiazide Aurobindo, Lisinopril/Hydrochloorthiazide Cf
- Norway · Lisinopril/Hydroklortiazid Actavis, Zestoretic
- Poland · Lisiprol Hct, Skopryl Plus
- Portugal · Ecamais, Lisinopril + Hidroclorotiazida Aurovitas
- Romania · Skopryl Plus
- Sweden · Lisinopril/Hydroklortiazid Actavis, Lisinopril/Hydroklortiazid Stada
- Slovenia · Iruzid, Liten Hct
- Slovakia · Diroton Plus H, Iruzid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d585598c-4caf-48ca-aaaa-dee2df3ede56 GET /v1/drugs/d585598c-4caf-48ca-aaaa-dee2df3ede56?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "12.5; 10",
"substance": "HYDROCHLOROTHIAZIDE; LISINOPRIL",
"productndc": "80425-0207",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA076230",
"marketing_category": "ANDA"
}See everything about hydrochlorothiazide; lisinopril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.